GENTEX CORP
For the period ended Jun 30, 2025. Filed Aug 8, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 8, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unaudited Condensed Consolidated Balance Sheets
As of June 30, 2025 and December 31, 2024
| June 30, 2025 (Unaudited) | December 31, 2024(Note) | |
|---|---|---|
| ASSETS | ||
| CURRENT ASSETS | ||
| Cash and cash equivalents | $119,774,840 | $233,318,766 |
| Short-term investments | 21,303,330 | 22,304,829 |
| Accounts receivable, net | 372,961,789 | 295,344,353 |
| Inventories, net | 475,719,663 | 436,497,445 |
| Prepaid expenses and other | 72,217,004 | 49,862,777 |
| Total current assets | 1,061,976,626 | 1,037,328,170 |
| PLANT AND EQUIPMENT—NET | 783,863,952 | 728,481,467 |
| OTHER ASSETS | ||
| Goodwill | 340,668,927 | 340,668,927 |
| Long-term investments | 267,045,895 | 339,604,044 |
| Intangible assets, net | 186,550,142 | 195,157,160 |
| Deferred tax asset | 90,692,041 | 53,154,832 |
| Patents and other assets, net | 83,019,753 | 66,426,375 |
| Total other assets | 967,976,758 | 995,011,338 |
| TOTAL ASSETS | $2,813,817,336 | $2,760,820,975 |
| LIABILITIES AND SHAREHOLDERS’ INVESTMENT | ||
| CURRENT LIABILITIES | ||
| Accounts payable | $204,675,277 | $168,314,912 |
| Short-term debt | 3,932,497 | — |
| Accrued liabilities | 128,326,091 | 84,377,764 |
| Total current liabilities | 336,933,865 | 252,692,676 |
| OTHER NON-CURRENT LIABILITIES | 43,755,486 | 36,028,644 |
| TOTAL LIABILITIES | 380,689,351 | 288,721,320 |
| REDEEMABLE NON-CONTROLLING INTEREST | 2,490,261 | — |
| SHAREHOLDERS’ INVESTMENT | ||
| Common stock | 13,171,245 | 13,632,448 |
| Additional paid-in capital | 998,911,809 | 1,010,440,420 |
| Retained earnings | 1,421,351,763 | 1,450,287,128 |
| Accumulated other comprehensive loss | (3,396,649) | (6,409,341) |
| TOTAL GENTEX CORPORATION SHAREHOLDERS' INVESTMENT | 2,430,038,168 | 2,467,950,655 |
| Non-controlling Interest | 599,556 | 4,149,000 |
| TOTAL SHAREHOLDERS' INVESTMENT | 2,430,637,724 | 2,472,099,655 |
| TOTAL LIABILITIES, REDEEMABLE NON-CONTROLLING INTEREST, AND SHAREHOLDERS' INVESTMENT | $2,813,817,336 | $2,760,820,975 |
Note: The condensed consolidated balance sheet at December 31, 2024 has been derived from the audited consolidated financial statements at that date, but does not include all of the inflation and footnotes required by accounting principles generally accepted in the United States for complete financial statements.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.